Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Vaccine Therapy in Treating Women With Metastatic Breast Cancer
Phase 3
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2004-05-03
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Oncothyreon Canada Inc.
- Target Recruit Count
- 950
- Registration Number
- NCT00003638
- Locations
- 🇨🇦
Biomira Inc., Edmonton, Alberta, Canada
Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients
Phase 2
Completed
- Conditions
- Breast Neoplasms
- First Posted Date
- 2002-10-10
- Last Posted Date
- 2008-01-23
- Lead Sponsor
- Oncothyreon Canada Inc.
- Registration Number
- NCT00046371
News
No news found